Curated Wealth Partners »

Neurocrine Biosciences shares owned by Curated Wealth Partners

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Curated Wealth Partners from 13F filings

Historical chart of Curated Wealth Partners investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Curated Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Curated Wealth Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $368k 2.7k 137.92
2023-12-31 $374k 2.8k 131.76
2023-09-30 $296k 2.6k 112.50

More positions owned by Curated Wealth Partners

Apollo Global Mgmt Put Option (APO)
Ares Management Corporation cl a com stk Put Option (ARES)
Spdr S&p 500 Etf Uie Put Option (SPY)
Vanguard S&p 500 Etf Uie Put Option (VOO)
Terex Corporation Put Option (TEX)
Apple Put Option (AAPL)
Microsoft Corporation Put Option (MSFT)
Rayliant Quntml Emg Mt Uie Put Option (RAYE)
Snap Inc cl a Put Option (SNAP)
Dimensional Intern Core Uie Put Option (DFAI)
Ishares Core S&p 500 Uie Put Option (IVV)
Amazon Put Option (AMZN)
Berry Plastics Put Option (BERY)
NVIDIA Corporation Put Option (NVDA)
Ares Capital Corporation Put Option (ARCC)

View all positions for Curated Wealth Partners

Top funds holding Neurocrine Biosciences

Vanguard Group
Bellevue Group
Jpmorgan Chase & Co
Henderson Group
T. Rowe Price Associates
Point72 Asset Management
Dodge & Cox
DSM Capital Partners
Wellington Management Company
Brown Advisory Holdings Incorporated
Bank of New York Mellon
Deerfield Management Company
Franklin Resources
Jacobs Levy Equity Management
AQR Capital Management

View all funds holding Neurocrine Biosciences